127.92CHF-0.08%Mkt Cap: 278.57B $P/E: 22.641d ago
Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to tre…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/E
Avg
P/B
Pricier
Div Yield
Lower
1M Perf
Lower
$1.08TUSDP/E 43.1
$633.19BUSDP/E 30.5
$461.26BUSDP/E 128.0
$314.36BUSDP/E 21.6
$319.99BUSDP/E 36.5
$284.58BUSDP/E 22.8
$276.37BUSDP/E 28.8
$243.69BUSDP/E 28.7
$210.73BUSDP/E 11.9
$201.93BUSDP/E 26.0
$162.98BUSDP/E 17.9
$138.61BUSDP/E 18.6
$118.71BUSDP/E 16.3
$98.63BUSDP/E 19.1
$87.73BUSDP/E 14.2
$56.98BUSD
$31.91BUSDP/E 23.3
MRV
Marvell Technology, Inc.$26.62BUSDP/E 10.1
$11.36BUSDP/E 22.8
$11.03BUSDP/E 19.1
$10.98BUSDP/E 19.1
$6.72BUSDP/E 14.9
$3.56BUSDP/E 14.6
$3.02BUSDP/E 18.4
$54.93MUSD
$39.70MUSD
ELXR
Elixxer Ltd.$9.51MUSD
FLXN
Horizon Flexible Income ETF—P/E 27.2
CELG-RI
Bristol-Myers Squibb Company Ce—
ROSE
DocMorris AG—
Indicators:|
Key Statistics
Company
Market Cap278.57B $
Enterprise Value321.90B $
Revenue (TTM)64.57B $
Gross Profit49.05B $
Net Income (TTM)15.96B $
Revenue/Share33.56 USD
Last Price127.92 CHF
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees75.3K
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012005267
Valuation
P/E (Trailing)22.64
P/E (Forward)16.06
PEG4.19
EV/EBITDA12.30
EV/Revenue4.99
P/S4.27
P/B7.86
EPS (TTM)5.65
EPS (Forward)7.88
52W Range
91.2092% of range131.00
52W High131.00 CHF
52W Low91.20 CHF
Profitability
Gross Margin75.83%
Oper. Margin30.48%
EBITDA Margin40.51%
Profit Margin24.67%
ROE30.31%
ROA12.60%
Growth
Revenue Growth-0.70%
Earnings Growth-9.30%
Cash Flow & Leverage
Operating CF21.85B $
CapEx (TTM)4.45B $
FCF Margin21.25%
FCF Yield4.93%
Net Debt45.77B $
Net Debt/EBITDA1.75
Balance Sheet
Debt/Equity0.77
Current Ratio0.85
Quick Ratio0.53
Book Value/Sh16.10 CHF
Cash/Share3.612 CHF
Dividends
Fwd Div Rate3.700 CHF
Trail. Div Rate4.666 CHF
Div. Yield2.93%
5Y Avg Yield3.59%
Payout Ratio66.26%
Ex-Div DateMar 10, 2026
Pay DateMar 13, 2025
Splits
Last Split6:5
Split DateOct 4, 2023
Analyst Consensus
Rating2.6 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)124.87 CHF
Upside (mean)-2.4%
Target Range97.85 CHF – 144.21 CHF
CHF97.85-2.4% to meanCHF144.21
# Analysts21
Ownership
Shares Out.1.91B
Float1.81B
Insiders2.11%
Institutions46.17%
Technical
SMA 50117.77 (+8.6%)
SMA 200113.79 (+12.4%)
Beta0.49
S&P 52W Chg20.05%
Avg Vol (30d)3.10M
Avg Vol (10d)3.77M
Technical Indicators
RSI (14)67.6
MACD2.5334
MACD Signal1.8659
MACD Hist.+0.6676
BB Upper129.25 CHF
BB Middle122.07 CHF
BB Lower114.90 CHF
BB Width11.76%
ATR (14)2.540 CHF
Vol Ratio (20d)0.56x